Close

Analyst Ratings for Prelude Therapeutics (PRLD) [Neutrals]

PRLD Rating Summary

PRLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PRLD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $5.25 (-7.2%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/20/2024 H.C. Wainwright Robert Burns Downgrade Neutral
(Buy)
5.00
(N/A)
4.63
(5.66)
22.25% Details
2/28/2022 Barclays
» Updated 8/4/2023
Peter Lawson Downgrade Equalweight
(Overweight)
5.00
(7.00)
10.60
(5.66)
-46.6% Details
Like PRLD Ratings? Also take a look at ABCL

PRLD Ratings News